Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging Ltd has reported an increase in quarterly revenue to $3.4 million, a notable rise from $3.0 million in the prior quarter, primarily driven by enhanced teleradiology utilization and improved margins. The company has reaffirmed its deployment goal of exceeding 100 units globally by year-end and has issued a revenue guidance of $35 million for 2026, reflecting anticipated growth and confidence in their business model. Additionally, a strategic partnership with 3DR Labs enhances the distribution of its AI imaging solutions to over 1,800 hospitals, thereby expanding its market presence and promoting early disease detection, which could further bolster revenue streams.

Bears say

Nano X Imaging Ltd reported a significant decrease in cash reserves, dropping to $55.5 million from $83.2 million, primarily due to an operating cash burn of $30.4 million. The company has consistently lowered its expectations for revenue growth, indicating potential challenges in achieving financial targets. Additionally, the elevated GAAP gross loss of $2.9 million, combined with a stable net loss of $13.7 million, underscores ongoing financial pressures tied to investments in system deployments and AI infrastructure.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.